Client News
Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)
4th January 2024
Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide
29th December 2023
CARBIOS publishes its second sustainability report and confirms its ambitions to accelerate the circular economy for plastic
21st December 2023
CARBIOS has received €1.2M of the €11.4M granted by ADEME to further optimize its unique PET depolymerization process and guarantee its competitiveness
20th December 2023
Lindis Blood Care Announces Last Patient Out in Multicenter Clinical Certification Study REMOVE with CATUVAB® to Eliminate Tumor Cells from Surgical Blood
20th December 2023
Rentschler Biopharma Announces Major Client Project for New U.S. Facility at Milford, MA Site
20th December 2023
Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees
19th December 2023
There is no more content to load